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Abstract
Aims
Fetuses affected by congenital heart defects (CHD) are considered to be at increased risk
of fetal growth restriction and intrauterine demise. Whether these risks are a direct conse-
quence of fetal CHD or a result of associated uteroplacental dysfunction is not evident from
the data of recent studies. The aim of this study was to investigate the prevalence of utero-
placental dysfunction reflected by abnormal uterine artery Doppler indices and reduced fetal
growth in CHD pregnancies.
Methods
This is a retrospective case-control study including singleton pregnancies referred for
detailed fetal cardiac assessment subsequently diagnosed with or without CHD. Mid-trimes-
ter uterine artery Doppler assessment at 20–24 weeks as well as third trimester fetal biome-
try and arterial Doppler pulsatility indices (PI) were performed. All fetal biometry were
converted into centiles and Doppler values to multiples of median (MoM) to adjust for physi-
ological changes with gestation.
Results
The study included 811 pregnancies including 153 cases where the fetus was diagnosed
with CHD. Mid-pregnancy uterine artery PI was significantly higher in women with fetal CHD
compared to controls (0.90MoM vs 0.83MoM; p = 0.006). In the third trimester, median cen-
tiles for fetal head circumference (45.4 vs 57.07; p<0.001), abdominal circumference (51.17
vs 55.71; p = 0.014), estimated fetal weight (33.6 vs 56.7; p<0.001) and cerebroplacental
ratio (CPR: 0.84MoM vs 0.95MoM; p<0.001) were significantly lower in fetuses with CHD
compared to controls. The percentage of small for gestational age births <10th centile
(24.0% vs 10.7%; <0.001) and low CPR <0.6MoM (11.7% vs 2.5%; p<0.001) were signifi-
cantly higher in the fetal CHD cohort.
PLOS ONE | https://doi.org/10.1371/journal.pone.0226741 February 5, 2020 1 / 10
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Binder J, Carta S, Carvalho JS, Kalafat E,
Khalil A, Thilaganathan B (2020) Evidence for
uteroplacental malperfusion in fetuses with major
congenital heart defects. PLoS ONE 15(2):
e0226741. https://doi.org/10.1371/journal.
pone.0226741
Editor: Frank T. Spradley, University of Mississippi
Medical Center, UNITED STATES
Received: April 26, 2019
Accepted: December 3, 2019
Published: February 5, 2020
Copyright: © 2020 Binder et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: This is a
retrospective study of routinely collected data and
we do not have patient consent to make it freely
available. However data is available on request.
Requests should be submitted to the Health
Research Authority (Skipton House, 80 London Rd,
Elephant and Castle, London SE1 6LH-
hrapublicinvolvement@nhs.net). A list of variables
is uploaded as a Supporting Information file.
Funding: The authors received no specific funding
for this work.
Conclusions
Mid-pregnancy uterine artery resistance is increased and subsequent fetal biometry
reduced in pregnancies with CHD fetuses. These findings suggest that fetal CHD are asso-
ciated with uteroplacental dysfunction, secondary to impaired maternal uteroplacental perfu-
sion resulting in relative fetal hypoxaemia and reduced fetal growth.
Introduction
Congenital heart defects (CHD) affect around 1% of live births and are considered the leading
cause of neonatal mortality due to birth defects [1]. Although the survival rates for fetal CHD
have improved, the risk of prenatal and postnatal brain abnormalities and neurodevelopmen-
tal delay in fetuses and neonates with CHD continues to be a significant problem [2, 3]. A
number of studies have provided data suggesting that the risk of neurological impairment is
not only a result of hypoxia during cardiac surgery [4], but also highlighted the link between
reduced fetal middle cerebral artery (MCA) pulsatility index (PI), reduced fetal cerebral oxy-
genation and a reduction in the brain volume [2, 5–7]. Consistent with fetal hypoxemia in
CHD, other studies have suggested the presence of placental dysfunction with significantly
higher umbilical artery (UA) Doppler PI and reduced fetal size [2, 5, 6].
Recent data suggest uteroplacental malperfusion as an additional or even underlying mech-
anism in fetuses with CHD describing decreased levels of placental like growth factor (PLGF)
in isolated major CHD in the first trimester, indicating impaired placentation [8, 9]. Moreover
soluble fms-like tyrosine kinase 1 (sFlt-1), vascular endothelial growth factor A and soluble
endoglin, markers of antiangiogenesis, were expressed in higher amounts in fetal heart tissue
and fetal cord blood when a CHD was present [10]. Furthermore maternal serum of women
carrying a fetus with a CHD showed decreased PLGF and increased sFlt1 levels, which is
hypothesized to be due to impaired placental angiogenesis [10].
Additionally, a subsequent prospective study evaluating uteroplacental perfusion in fetuses
with CHD in the first trimester was also able to demonstrate placental dysfunction represented
by low pregnancy-associated plasma protein A (PAPP-A) and placental like growth factor
(PlGF). However, this study did not assess uteroplacental perfusion reflected by uterine artery
doppler indices [11]. The aim of this study was to ascertain whether pregnancies complicated
by fetal CHD exhibited Doppler features consistent with maternal uteroplacental malperfusion
and ultrasound/Doppler evidence of fetal growth restriction.
Materials and methods
Study population and patient characteristics
The Wandsworth Research Ethics Committee waived the requirement for review and approval
by a Research Ethics Committee and for patient consent to access of identified clinical data by
the lead author.
This is a retrospective cross sectional case control study, including data from all pregnant
women referred to the Fetal Medicine Unit at St George’s Hospital (SGH) for detailed fetal car-
diology assessment after 20 weeks’ gestation, between January 2009 and January 2016. Major
congenital fetal heart defect was defined as a structural heart defect that was likely to require
surgical repair. The cases also had further third trimester fetal assessment, which included fetal
biometry, UA and MCA Doppler evaluation by a fetal medicine specialist. Uterine Artery
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(UtA) Doppler assessment was done in the second trimester after referral to SGH as per unit
protocol to screen for preeclampsia and intrauterine growth restriction.
Control pregnancies underwent the same standard of cardiac and fetal medicine assessment
due to family history of fetal heart abnormalities, suspected fetal heart abnormality or medica-
tion intake that might affect normal formation of the fetal heart, but had a final prenatal and
postnatal diagnosis of normal heart structure and function. The exclusion criteria consisted of
chromosomal or genetic abnormalities, minor cardiac defects, isolated venous system anoma-
lies, prenatal fetal cardiac intervention/therapy, non-structural cardiac abnormalities (such as
arrhythmias and cardiomegaly), extra-cardiac abnormalities, fetal infections causing hyperdy-
namic circulation, multiple pregnancies and maternal conditions that might affect fetal hemo-
dynamics, growth or placental vascularization (such as hypertensive disorders, preeclampsia,
thyroid disorders, autoimmune disorders and diabetes). Prenatal invasive testing and chromo-
somal testing were offered to all pregnant women diagnosed with a major congenital heart
defect. Postnatal confirmation of the cardiac defect detected during pregnancy was performed
by a pediatric/fetal cardiologist. Genetic testing was done postnatally if applicable, leading to
exclusion of the study if chromosomal or genetic abnormalities were present.
CHD defects were divided into subgroups according to their expected pattern of blood sup-
ply to the brain as described by Masoller et al.[7] They were grouped into CHD with low pla-
cental blood delivered to the brain due to severe left ventricular outflow obstruction and CHD
with mixed systemic and placental blood due to intracardial shunts[7].
Ultrasound and Doppler technique
Fetal Doppler parameters were taken automatically from consecutive waveforms and the angle
of insonation used was below 30˚. The UA Doppler waveform was measured after sampling a
free-floating portion of the umbilical cord using colour Doppler imaging. Consequently, the
UA pulsatility index was calculated according to a standard protocol [12]. The MCA was iden-
tified at the level of its origin from the circle of Willis using colour Doppler after obtaining a
transverse section of the fetal head. The MCA was sampled at the position where the vessel
passes the sphenoid wing using Pulsed Doppler. The MCA PI was determined according to
standard protocol [13]. The CPR was calculated as the ratio MCA-PI/UA-PI [14]. Uterine
artery Doppler was assessed using colour Doppler to visualize the left and right uterine arteries
at the level of the cross over with the external iliac artery. Pulsed-wave Doppler was applied to
assess impedance to flow and the PI was measured over three consecutive waveforms. The
mean value of the right and left UtA-PI was subsequently calculated [15]. All Doppler indices
were converted into multiples of the median (MoM), correcting for gestational age in weeks
[13–15]. EFW was calculated from the biparietal diameter, head and abdominal circumference
and femur length using the Hadlock formula [16]. Birthweight (BW) and EFW values were
converted into centiles [17]. Data on maternal characteristics, included age, body mass index
and ethnic origin, obstetric and maternal medical history, ultrasound scans (biometry and
Doppler evaluation in the second and third trimester), genetic testing, pregnancy outcomes
and neonatal assessment, were retrieved for all included pregnant women using the Viewpoint
obstetric ultrasound database (Viewpoint Inc., USA), Euroking K2 Maternity System and the
neonatal records.
Statistical analysis
Continuous variables were presented as median with interquartile ranges whereas binary vari-
ables were presented as numbers with percentages. Distribution assumptions for the variables
were tested with Shapiro-Wilk test. Group comparisons were made with t-test when normal
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distribution assumptions were satisfied, otherwise Mann-Whitney-U test was used. The Fish-
er’s exact test was used for comparison of binary outcomes. P values below 0.05 were consid-
ered statistically significant. All group comparisons were made with two-tailed tests. The
analysis was performed using the R for statistical computing software (Version 3.2.3, R Foun-
dation for Statistical Computing, Vienna, Austria). The Kruskal Wallis Test was used to evalu-
ate differences in UtA PI MoM in different subgroups of CHD.
Results
The study included 811 pregnancies (153 CHD cases and 658 controls) with a total of 1622
scans (811 echocardiograms and 811 anomaly/growth scans). The spectrum of major fetal car-
diac abnormalities in the study population is shown in Table 1.
Maternal characteristics and pregnancy outcomes are shown in Table 2. In contrast to the
controls that were all live born, in the CHD group there were 14 terminations of pregnancy, 6
stillbirths and 5 neonatal deaths. The diagnosis of CHD was confirmed after birth in the
remaining 125 cases. The median gestational age (GA) at delivery was significantly lower in
the CHD cases compared to controls (38.9 versus 39.9; p<0.001), as was the median birth
weight centile (31.3 vs 44.1; p = 0.002) and the prevalence of small for gestational age births
<10th centile (24.0% vs 10.7%;<0.001).
The details of the ultrasound and Doppler assessments are shown in Table 3. The median
fetal head circumference (45.43 vs 57.07; p<0.001), abdominal circumference (51.17 vs 55.71;
p = 0.014) and estimated fetal weight (EFW) centiles (33.60 vs 56.73; p<0.001) were signifi-
cantly lower in fetuses with CHD compared to controls (Table 3). The mid-pregnancy median
UtA PI MoM (0.90 vs 0.83; p = 0.006) and UA PI MoM (1.05 vs 0.97; p<0.001) were signifi-
cantly higher in fetuses with CHD when compared to healthy controls (Table 3, Fig 1). The
median MCA PI MoM (0.93 vs 0.97; p = 0.003) and CPR MoM (0.84 vs 0.95; p<0.001) were sig-
nificantly lower in fetuses with CHD than controls (Table 3, Fig 1). The percentage of low CPR
<0.6MoM cases (11.7% vs 2.5%; p<0.001) were significantly higher in the fetal CHD cohort.
Table 1. Types of congenital heart defects included in this study.
Type of congenital heart defect Number
Ventricular septal defect 23
Transposition of great arteries (TGA) 13
Tetralogy of Fallot 21
Hypoplastic left heart syndrome 9
Aortic stenosis 2
Coarctation of the aorta 18
Congenitally Corrected TGA 1
Atrioventricular septal defect 10
Double outlet right ventricle 6
Double aortic arch 1
Ebstein´s anomaly 1
Pulmonary atresia 10
Pulmonary stenosis 8
Tricuspid Atresia 7
Interrupted aortic arch 1
Complex abnormalities� 22
Total 153
�Complex CHD not classifiable in any of the other above reported categories.
https://doi.org/10.1371/journal.pone.0226741.t001
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Subgroup analysis of UtA PI MoM values according to the expected blood supply to the
brain (low placental supply and mixed placental and systemic supply) revealed non- significant
differences (low placental supply median UtA MoM 0.90, Interquartile range- IQR 0.73–1.07;
mixed placental and systemic supply, median UtA PI MoM 0.91, IQR 0.75–1.06; p = 0.653).
Discussion
Summary of study findings
The findings of this study demonstrate that mid-gestational uterine artery PI indices were sig-
nificantly higher, fetal biometry in the third trimester was significantly smaller and fetal Dopp-
ler indices were suggestive of uteroplacental dysfunction and fetal hypoxemia in fetuses with
CHD compared to normal pregnancies.
Clinical and research implications
Significantly higher second trimester mean uterine artery PI in fetuses affected by CHD, as
demonstrated in this study, is related to impaired placentation. In combination with signifi-
cantly lower birth weight centiles of CHD cases and lower MCA Doppler indices, higher
Table 2. Description of the study groups.
Congenital heart defects
(n = 153)
Controls
(n = 658)
p value
Maternal age (years) 31.00 (28.00–34.00) 32.00 (28.00–36.00) 0.058
Self-reported ethnicity 0.042
Asian 18 (11.8) 108 (16.4)
Black 17 (11.1) 79 (12.0)
Caucasian 103 (67.3) 437 (66.4)
Mixed 3 (2.0) 24 (3.6)
Other 4 (2.6) 2 (0.3)
Missing 8 (5.2) 8 (1.2)
Outcome of pregnancy <0.001
Intrauterine death 6 (3.9) 0 (0.0)
Termination 14 (9.2) 0 (0.0)
Live birth 125 (81.7) 658 (100.0)
Neonatal death 5 (3.3) 0 (0.0)
Missing 3 (1.9) 0 (0.0)
Gestational age at delivery (weeks) 38.86 (36.96–39.57) 39.86 (39.00–40.86) <0.001
Mode of delivery 0.013
Vaginal delivery 61 (39.9) 378 (57.4)
Instrumental delivery 12 (7.8) 103 (15.7)
Elective caesarean 29 (19.0) 93 (14.4)
Emergency caesarean 19 (12.4) 74 (11.2)
Missing 32 (20.9) 10 (1.5)
Neonatal sex (male) 51.9 (%) 52.8 (%) 0.857
Birth weight (grams) 3120 (2642–3400) 3355 (3037–3690) <0.001
Birth weight centile 31.31 (10.36–64.20) 44.13 (20.09–70.51) 0.002
Birth weight <10th centile 24.0 (%) 10.7 (%) <0.001
The values are presented as number (%) or Median (interquartile range). Group comparisons were made with Mann-Whitney-U, Chi-Square or Fisher’s exact where
appropriate
https://doi.org/10.1371/journal.pone.0226741.t002
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second trimester mean uterine artery PI is indicative of redistribution suggestive of fetal hyp-
oxemia; all these findings support uteroplacental dysfunction interrelating to growth restric-
tion in CHD fetuses. Our findings are consistent with those by Ruiz et al., who demonstrated
that the uterine artery PI is greater than the 95th centile in 61% of 115 CHD pregnancies.
These results were again suggestive of uteroplacental dysfunction, even though the authors
included a smaller number of CHD cases, did not include an appropriate control group and
reported only on trends with gestational age [18].
Although the exact underlying mechanism leading to uteroplacental dysfunction is not yet
fully understood, the association of the latter with fetal CHD is supported by the fact that the
placenta and the fetal heart form concurrently at around day 21 of gestation[19]. Moreover
placental and heart development share common pathways including the Notch and Wnt path-
way which regulate both the specification of cardiomyocites and extra villous throphoblast
invasion[20, 21]. Vascular cell adhesion protein (VCAM) 1, which mediates the adhesion of
lymphocytes and monocytes to the vascular endothelium, shows lower levels in babies with
fetal growth restriction[22]. A disruption of VCAM 1 described in a mouse model results in
impaired placentation leading to both fetal demise and the presence of severe malformations
of the fetal heart [23, 24].
As mentioned earlier, Llurba et al. [10] reported an imbalance in the sFlt-1 (soluble fms-
like tyrosine kinase 1) and placental like growth factor (PlGF) levels in pregnant women carry-
ing fetuses with CHD–a recognised finding in fetal growth restriction [25]. They suggested
that uteroplacental dysfunction and resulting fetal hypoxemia might proceed to the subsequent
formation of cardiac abnormalities in these fetuses as well as the complications of preeclampsia
and fetal growth restriction [10]. This hypothesis is supported by animal studies on zebra fish
embryos where a blockage of the VEGF receptor was associated with the formation of an
abnormal fetal heart [26]. The imbalance of angiogenic factors seen in manifestations of utero-
placental dysfunction such as preeclampsia and fetal growth restriction, suggest an important
Table 3. Biometry and Doppler parameters in the study groups.
CHD (n = 153) Controls (n = 658) p value
Mid-pregnancy uterine Doppler
Gestation at Doppler (weeks) 21.86 (21.14–22.93) 21.86(21.57–22.29) 0.947
Mean uterine artery PI multiple of median (MoM) 0.90 (0.73–1.06) 0.83 (0.68–0.98) 0.006
Third trimester fetal biometry assessment
Gestation at ultrasound (weeks) 31.00 (22.29–34.29) 36.00 (28.29–37.14) <0.001
Biparietal diameter centile 36.23 (17.18–62.12) 47.87 (27.49–67.89) 0.004
Head circumference (HC) centile 45.43 (22.01–66.27) 57.07 (37.43–71.76) <0.001
Abdominal circumference (AC) centile 51.17 (25.89–69.74) 55.71 (39.37–71.03) 0.014
Estimated fetal weight (EFW) centile 33.60 (0.13–68.28) 56.73 (19.71–78.14) <0.001
EFW <10th centile 35.3 (%) 22.3 (%) <0.001
Fetal Doppler assessment
Umbilical artery PI MoM 1.05 (0.89–1.18) 0.97 (0.86–1.08) <0.001
Middle cerebral artery PI MoM 0.93 (0.80–1.05) 0.97(0.87–1.09) 0.003
Umbilical cerebral ratio MoM 1.11 (0.93–1.36) 0.99 (0.84–1.15) <0.001
Cerebroplacental ratio MoM 0.84 (0.69–1.01) 0.95 (0.81–1.12) <0.001
Cerebroplacental ratio MoM <0.6 11.7 (%) 2.5 (%) <0.001
The values are presented as number (%) or Median (interquartile range). Group comparisons were made with Mann-Whitney-U, Chi-Square or Fisher’s exact where
appropriate.
https://doi.org/10.1371/journal.pone.0226741.t003
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primary or secondary role of uteroplacental function contributing to the development of
CHD. Data on differences in uteroplacental perfusion in larger cohorts of CHD stratified by
different subgroups, which might be at particular risk for placental insufficiency, are lacking.
Analysis of our data in this study did not reveal significant differences between subgroups of
Fig 1. Scatter plots of the cerebroplacental ratio (Fig 1A) multiple of median (MoM) and the uterine artery MoM (Fig 1B) in the fetuses with congenital heart defects
compared to normal fetuses. The dots represent individual values for patients. The middle bar represents the median for that sample and upper and lower bars represent
interquartile ranges.
https://doi.org/10.1371/journal.pone.0226741.g001
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CHD according to UtA PI MoM, suggesting no greater risk for the development of placental
insufficiency in specific subgroups of CHD.
Strengths and weaknesses
The strength of our study includes the relatively large sample size of fetuses with CHD and
healthy fetuses with both fetal cardiac evaluation by a fetal cardiologist and uterine artery
Doppler assessment. However, the main limitations are its retrospective nature and the non-
consecutive case selection, the latter introducing the possibility of selection bias. Moreover, the
number of fetuses with CHD was limited and subgroups of CHD were small. Therefore the
analysis for differences in UtA PI MoM between different subgroups of CHD might have been
underpowered and the lack of significance might be due to the small sample size. Larger pro-
spective studies also analysing different subtypes of CHD are necessary to evaluate the role of
uteroplacental perfusion and placentation as underlying mechanisms contributing to both
CHD and preeclampsia in these patients. Furthermore the inclusion of maternal outcome
parameters such as the prevalence of preeclampsia or chronic hypertension resulting in pla-
cental insufficiency would have been favourable. However, the study was not designed or ade-
quately powered to proof a causal relationship between the presence of CHD and preeclampsia
as described by Boyd et al [27] in a cohort of two million pregnant women, hence a regression
analysis for preeclampsia was not performed.
Conclusion
In this study, we were able to demonstrate significant differences in uteroplacental perfusion
indices in pregnant women with fetuses affected by CHD compared to healthy pregnant con-
trols, suggesting a potential contributing role of impaired uteroplacental perfusion in the path-
ogenesis of fetal CHD. The additional findings of smaller fetuses and Doppler indices of
relative fetal hypoxemia suggest that CHD pregnancies are characterized by impaired uteropla-
cental perfusion, a known risk factor for preeclampsia. Further research is necessary to clarify
the underlying mechanisms leading to fetal CHD, with a special focus on the role of impaired
uteroplacental perfusion in women carrying a fetus with CHD.
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